Emerging Therapies for Transthyretin Cardiac Amyloidosis
Sign Up to like & getrecommendations! Published in 2019 at "Current Treatment Options in Cardiovascular Medicine"
DOI: 10.1007/s11936-019-0743-2
Abstract: Transthyretin cardiac amyloidosis is an underdiagnosed, undertreated disease which is associated with significant morbidity and mortality. This review will discuss the recent advancements in novel therapies for transthyretin amyloidosis. In recent phase 3 clinical trials,… read more here.
Keywords: transthyretin amyloidosis; therapies transthyretin; amyloidosis; emerging therapies ... See more keywords